Navigation Links
Controlling parasitic worms with genetic selection
Date:12/19/2013

Helminths are gastrointestinal parasitic worms that have become a major concern and source of economic loss for sheep producers around the world. A new article published today in the Canadian Journal of Animal Science reviews current research into a promising alternative to control the disease.

According to the paper, the sheep industry has become dependent on drugs to control these parasites. Over time these drugs are less effective as helminths become resistant to the drugs. Therefore, there is pressure on the industry to find alternate strategies. One such strategy is genetic selection. Certain breeds of sheep are more immune to helminths than the conventional breeds used in Canada, and a breeding program that aims to pass on this resistance trait could help to control the disease and ultimately limit production losses attributed to helminth infection.

A key advantage to applying genetic selection rather than chemicals to get rid of the worms is that it is permanent and it could help reduce the potential risk of chemical residues in products made for human consumption. This is key for the public as well as the sheep industry.

"With today's developments in genomic selection, breeding sheep for helminth resistance can be achieved efficiently, without adversely affecting other economically important traits," explained Niel Karrow, lead author of the paper, a researcher at the Centre for Genetic Improvement of Livestock at the University of Guelph.

"We believe that breeding for helminth resistance, when combined with good biosecurity and pasture management practises, will greatly help to control against production losses due to gastrointestinal parasites."


'/>"/>

Contact: Jenny Ryan
jenny.ryan@nrcresearchpress.com
Canadian Science Publishing (NRC Research Press)
Source:Eurekalert

Page: 1

Related biology news :

1. Oregon scientists offer new insights on controlling nanoparticle stability
2. Controlling the triggers of age-related inflammation could extend healthspan
3. Controlling genes with light
4. Cell-permeable peptide shows promise for controlling cardiovascular disease
5. White blood cells found to play key role in controlling red blood cell levels
6. New approaches for controlling pesticide exposure in children
7. Discovery of Africa moth species important for agriculture, controlling invasive plants
8. Could chloroplast breakthrough unlock key to controlling fruit ripening in crops?
9. New neural pathway controlling skeletal development discovered
10. Controlling gait of horses may be possible, says key study from Texas A&M
11. Controlling gene expression: How chromatin remodelers block a histone pass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
(Date:12/16/2016)... YORK , Dec. 16, 2016 The global wearable ... USD 12.14 billion by 2021 from USD 5.31 billion in 2016, ... ... is mainly driven by technological advancements in medical devices, launch of ... rising preference for wireless connectivity among healthcare providers, and increasing focus ...
(Date:12/15/2016)... Dec 15, 2016 ... Research and Markets has announced the addition of ... The report forecasts the global military biometrics market to ... The report has been prepared based on an in-depth market analysis ... its growth prospects over the coming years. The report also includes a ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... PUNE, India , Jan. 19, 2017  Market Research Future ... The Global Market for Liquid Biopsy is growing rapidly and expected ... period. Market Highlights ... The Global Liquid Biopsy Market has been assessed as ... high growth figures and boom in the coming future. There has ...
(Date:1/19/2017)... /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, ... platform, today announced that it has acquired HD ... discovery contract research organization (CRO). After completion of ... of WuXi, and will continue to focus on ... The acquisition will further strengthen WuXi,s R&D capability ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... development (R&D), today announced the launch of Data Science Services , ... rapidly evolving field of precision medicine. , Data Science Services allows ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , ... PIP) and Altimmune, Inc., a privately-held immunotherapeutics company ... a definitive agreement for the merger of PharmAthene ... investors include Novartis Venture Fund, HealthCap, Truffle Capital ... a fully-integrated and diversified immunotherapeutics company with four ...
Breaking Biology Technology: